(Q47294978)

English

Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICT

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICT (English)

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin detemir

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Meneghini LF

1

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

Rosenberg KH

2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

Koenen C

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

Merilainen MJ

4

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

Lüddeke HJ

5

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

publication date

1 May 2007

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

9

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

418-427

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Tissue selectivity of insulin detemir action in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Post-marketing surveillance: a UK/European perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Methodologic issues in observational studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00674.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2006.00674.X

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/17391170

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47294978&oldid=1563400978"